Related references
Note: Only part of the references are listed.Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study
L. Beltrame et al.
ANNALS OF ONCOLOGY (2015)
Impact of National Cancer Institute Comprehensive Cancer Centers on Ovarian Cancer Treatment and Survival
Robert E. Bristow et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience
Giuseppe Vizzielli et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma
Zhiqun Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
Aditya Parikh et al.
NATURE COMMUNICATIONS (2014)
A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer
Anna Fagotti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
Sergio Marchini et al.
EUROPEAN JOURNAL OF CANCER (2013)
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
Benjamin Boyerinas et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
Mohd Saif Zaman et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer
Ignace Vergote et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Share Paper
